logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 4
  • 1
    Lam, Chi Ho Andre
    Born in May 1997
    Individual (2 offsprings)
    Officer
    2023-01-31 ~ now
    OF - Director → CIF 0
  • 2
    Chung, Kar Man
    Born in March 1970
    Individual (9 offsprings)
    Officer
    2022-07-06 ~ now
    OF - Director → CIF 0
  • 3
    Tanna, Divya
    Born in February 1959
    Individual (26 offsprings)
    Officer
    2022-07-06 ~ now
    OF - Director → CIF 0
    Mr Divya Tanna
    Born in February 1959
    Individual (26 offsprings)
    Person with significant control
    2022-07-06 ~ 2023-01-26
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 4
    AMMONITE PHARMACEUTICALS LTD
    - now 14602226
    AMMONITE PHARMCEUTICALS LTD - 2023-01-19
    4th Floor Elsley Court, 20-22 Great Titchfield Street, London, United Kingdom
    Active Corporate (5 parents, 1 offspring)
    Person with significant control
    2023-01-26 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
parent relation
Company in focus

LAKEWOOD PHARMACY LIMITED

Period: 2022-07-06 ~ now
Company number: 14217383
Registered name
LAKEWOOD PHARMACY LIMITED - now
Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Average Number of Employees
62024-04-01 ~ 2025-03-31
52023-04-01 ~ 2024-03-31
Intangible Assets
206,649 GBP2025-03-31
221,096 GBP2024-03-31
Property, Plant & Equipment
36,031 GBP2025-03-31
10,806 GBP2024-03-31
Fixed Assets
242,680 GBP2025-03-31
231,902 GBP2024-03-31
Total Inventories
80,139 GBP2025-03-31
85,000 GBP2024-03-31
Debtors
Current
113,571 GBP2025-03-31
87,665 GBP2024-03-31
Cash at bank and in hand
186,441 GBP2025-03-31
182,179 GBP2024-03-31
Current Assets
380,151 GBP2025-03-31
354,844 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-503,502 GBP2025-03-31
Net Current Assets/Liabilities
-123,351 GBP2025-03-31
-177,765 GBP2024-03-31
Total Assets Less Current Liabilities
119,329 GBP2025-03-31
54,137 GBP2024-03-31
Net Assets/Liabilities
109,036 GBP2025-03-31
51,435 GBP2024-03-31
Equity
Called up share capital
1 GBP2025-03-31
1 GBP2024-03-31
Retained earnings (accumulated losses)
109,035 GBP2025-03-31
51,434 GBP2024-03-31
Equity
109,036 GBP2025-03-31
51,435 GBP2024-03-31
Intangible Assets - Gross Cost
Goodwill
250,772 GBP2025-03-31
250,772 GBP2024-03-31
Intangible Assets - Gross Cost
261,439 GBP2025-03-31
250,772 GBP2024-03-31
Computer software
10,667 GBP2025-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Goodwill
54,753 GBP2025-03-31
29,676 GBP2024-03-31
Intangible Assets - Accumulated Amortisation & Impairment
54,790 GBP2025-03-31
29,676 GBP2024-03-31
Intangible Assets - Increase From Amortisation Charge for Year
25,114 GBP2024-04-01 ~ 2025-03-31
Intangible Assets
Goodwill
196,019 GBP2025-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,000 GBP2025-03-31
2,000 GBP2024-03-31
Office equipment
16,562 GBP2025-03-31
3,211 GBP2024-03-31
Computers
6,607 GBP2025-03-31
6,440 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
46,379 GBP2025-03-31
13,825 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
919 GBP2025-03-31
558 GBP2024-03-31
Office equipment
2,103 GBP2025-03-31
595 GBP2024-03-31
Computers
3,360 GBP2025-03-31
1,764 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
10,348 GBP2025-03-31
3,019 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
1,596 GBP2024-04-01 ~ 2025-03-31
Owned/Freehold
7,329 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Plant and equipment
1,081 GBP2025-03-31
1,442 GBP2024-03-31
Office equipment
14,459 GBP2025-03-31
2,616 GBP2024-03-31
Computers
3,247 GBP2025-03-31
4,676 GBP2024-03-31
Finished Goods/Goods for Resale
80,139 GBP2025-03-31
85,000 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
50,321 GBP2025-03-31
43,193 GBP2024-03-31
Other Debtors
Current
28,926 GBP2025-03-31
29,108 GBP2024-03-31
Prepayments/Accrued Income
Current
34,324 GBP2025-03-31
15,364 GBP2024-03-31
Trade Creditors/Trade Payables
Current
143,360 GBP2025-03-31
82,047 GBP2024-03-31
Amounts owed to group undertakings
Current
327,071 GBP2025-03-31
399,447 GBP2024-03-31
Corporation Tax Payable
Current
17,871 GBP2025-03-31
23,209 GBP2024-03-31
Other Creditors
Current
8,854 GBP2025-03-31
13,271 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
6,346 GBP2025-03-31
14,635 GBP2024-03-31
Creditors
Current
503,502 GBP2025-03-31
532,609 GBP2024-03-31
Net Deferred Tax Liability/Asset
-10,293 GBP2025-03-31
-2,702 GBP2024-03-31
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-7,591 GBP2024-04-01 ~ 2025-03-31
Deferred Tax Liabilities
Accelerated tax depreciation
-10,293 GBP2025-03-31
-2,702 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2025-03-31
1 shares2024-03-31
Par Value of Share
Class 1 ordinary share
1.002024-04-01 ~ 2025-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
22,500 GBP2025-03-31
22,500 GBP2024-03-31
Between one and five year
33,750 GBP2025-03-31
56,250 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
56,250 GBP2025-03-31
78,750 GBP2024-03-31
  • LAKEWOOD PHARMACY LIMITED
    Info
    Registered number 14217383
    4th Floor Elsley Court, 20-22 Great Titchfield Street, London W1W 8BE
    PRIVATE LIMITED COMPANY incorporated on 2022-07-06 (3 years 10 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-07-05
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.